Disappointing that the revenue generating side of things should have had resources diverted from it and so been unable to continue its run of increases. The increasing revenue has up to now been the bright spot.
- Forums
- ASX - By Stock
- Ann: Appendix 4D and Interim Financial Report
PIQ
proteomics international laboratories ltd
Add to My Watchlist
1.72%
!
29.5¢

Disappointing that the revenue generating side of things should...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $47.42M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 29.0¢ | $44.89K | 149.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3712 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 12527 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3712 | 0.295 |
4 | 23542 | 0.290 |
1 | 10000 | 0.285 |
4 | 40643 | 0.280 |
5 | 147912 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 12527 | 1 |
0.305 | 5712 | 2 |
0.310 | 1712 | 2 |
0.325 | 52573 | 1 |
0.330 | 2000 | 1 |
Last trade - 10.42am 27/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online